Class / Patent application number | Description | Number of patent applications / Date published |
424431000 | Tampon | 16 |
20080206309 | ANTAGONISTS OF PROSTAGLANDIN RECEPTORS EP2 AND/OR EP4 FOR THE TREATMENT OF DYSMENORRHEA AND MENORRHAGIA - A method of treating menorrhagia and/or dysmenorrhoea in a patient the method comprising administering to the patient an antagonist of a prostaglandin EP2 and/or EP4 receptor. Preferably the patient is a human female. | 08-28-2008 |
20080248087 | ABSORBENT ARTICLE - An absorbent article has an absorbent material and an outer surface including an inhibitor which is partially bound to the absorbent material and substantially inhibits the colonization of bacteria within the absorbent article. | 10-09-2008 |
20080254098 | Neural tube birth defect reduction with folic acid delivery in catamenial hygiene products - A method and apparatus of fortifying a population of fertile age women with folic acid to reduce the incidence of neural tube birth defects involves placing folic acid either in powder, microcapsule, gel, cream, tablet, capsule or other form in or on a feminine hygiene product such as a tampon or a menstrual pad and making such products available to the population of women so that their normal use of the tampons or other feminine hygiene products will result in absorption of a sufficient amount of folic acid to satisfy RDA requirements for women who may or have become pregnant. In certain embodiments, vitamin B12 and/or other nutrients or ingredients are added to the folic acid vehicle. | 10-16-2008 |
20090035353 | NON-ABSORBENT ARTICLES CONTAINING ADDITIVES - Non-absorbent articles containing an additive are disclosed. The non-absorbent articles include an effective amount of an inhibitory compound such as cerulenin, triclosan, or hexachloroprene, for example, to substantially inhibit the production of TSST-1 by Gram positive bacteria. | 02-05-2009 |
20090104249 | Exotoxin Inhibitory Factor - The invention provides an exotoxin inhibitory factor, compositions containing the factor, methods of using the compositions. | 04-23-2009 |
20090208558 | Use of Combination Preparations Comprising Antifungal Agents - The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of | 08-20-2009 |
20090297585 | pH Modulated Films for Delivery of Actives - pH modulated films and methods of their preparation. The film compositions include at least one component having a non-neutral pH when combined with water; and a pH modulated polymer system selected to reduce or prevent synerisis when combined with the non-neutral component in combination with aqueous media. The films demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, extrusion process, or other process that maintains the required uniformity of the film. | 12-03-2009 |
20100136088 | MAGNETIZABLE TAMPON DEVICE - In a tampon device ( | 06-03-2010 |
20100136089 | LOCATION OF FATTY ACID ESTERS ON TAMPONS AND TOXIN INHIBITING EFFICACY - The application of active ingredients, exemplified by GML, to absorbent fibers, such as rayon fibers, used in tampon manufacture at very low levels has been found to maintain efficacy in the inhibition of the production of toxic shock syndrome toxin one (TSST-1) produced by | 06-03-2010 |
20100285095 | Hygiene Article Having Calcium Sugar Acid Salt - A hygiene article having calcium sugar acid salt is provided. The calcium sugar acid salt reduces the production of Toxic Shock Syndrome Toxin-1 (TSST-1) by | 11-11-2010 |
20100285096 | Hygiene Article Having Calcium Sugar Phosphate - A hygiene article having calcium sugar phosphate is provided. The calcium sugar phosphate reduces the production of Toxic Shock Syndrome Toxin-1 (TSST-1) by | 11-11-2010 |
20110165220 | DRUGS TO PREVENT HPV INFECTION - A method of inhibiting HPV virus infection is disclosed. In one embodiment, the method involves exposing a papillomavirus to an effective amount of a compound selected from the group consisting of Compound 13, Compound 14, and analogs of Compounds 13 and 14. In another embodiment, the method involves administering an inhibitor selected from the group consisting of Compound 13, Compound 14, and analogs of Compounds 13 and 14 to a susceptible tissue or cell. | 07-07-2011 |
20110189258 | METHOD AND COMPOSITIONS FOR INHIBITION OF DOUBLE STRANDED DNA VIRUSES - A method of inhibiting double-stranded DNA virus infection is disclosed. In one embodiment, the method involves exposing a papillomavirus to an effective amount of an inhibitor selected from the group of G1, S, G2, and M cell cycle inhibitors. In another embodiment, the method involves administering an inhibitor selected from the group of G1, S, G2, and M cell cycle inhibitors to a susceptible tissue or cell. | 08-04-2011 |
20110280922 | DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES - The invention relates to a therapeutic device for the delivery of therapeutic agents, e.g. a peptide such as leuprolide, via the vagina to a female mammal. In some embodiments, the invention also relates to methods for the treatment of obesity and eating disorders, diabetes, multiple sclerosis (MS), endometriosis, uterine fibroids, polycystic ovarian disease, various cancers such as breast cancer, acne, hirsutism, microbial or fungal or viral infections such as bacterial vaginosis or AIDS/HIV, and chronic diseases using a disclosed vaginal device. | 11-17-2011 |
20140030312 | USE OF COMBINATION PREPARATIONS COMPRISING ANTIFUNGAL AGENTS - The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of | 01-30-2014 |
20160095953 | HEMOSTATIC DEVICE - A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site. | 04-07-2016 |